Law360, New York (February 17, 2010, 6:52 PM ET) -- A New Jersey state court jury has smacked drugmaker Hoffmann-La Roche Inc. with a $25.2 million dollar verdict in a case brought by a man who claimed the acne drug Accutane was responsible for the inflammatory bowel disease that led to the loss of his colon.
The verdict came down Tuesday in the New Jersey Superior Court and followed a five-week trial and about three and a half days of jury deliberation, according to Michael Hook, who represents plaintiff and former Accutane user Andrew McCarrell....
Roche Hit With $25M Accutane Verdict
To view the full article, take a free trial now.
